RP Cure Tracker

Trials / NCT02309866

Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases

Status unknown Observational Natural history / observational

Sponsor
Hillel Yaffe Medical Center
Treatment
Genetic testing
Gene
Not stated
Conditions
Retinitis Pigmentosa
Ages
Any to no upper limit
Enrollment
100 participants
Started
2015-01
Main results expected
2017-01
Results posted
Not yet
Record last updated
2014-12-05

What the study is testing

Retinitis Pigmentosa (RP) is the most common form of hereditary retinal degeneration, with a worldwide prevalence of 1:3500. It is one of the most genetically heterogenous conditions in humans, with over 100 causative genes and loci reported to date. However, in approximately 40% of patients the underlying genetic causes are yet to be found.

The current study aims to identify causative RP genes and mutations in Israeli families of various ethnic backgrounds. Identification of such genes will contribute significantly to disease prevention (by identification of high risk families and appropriate genetic counseling) and to the investigators understanding of retinal structure and function and of the etiology of RP.

Where it runs

No sites listed yet.

Open on ClinicalTrials.gov for contacts and eligibility